Stroke is a major public health concern worldwide, and 25% of stroke victims would have another stroke. Although administration of antiplatelet agents has been confirmed to be one of the major approaches for secondary prevention of noncardioembolic stroke, the short-term or long-term use of aspirin plus clopidogrel for secondary stroke prevention remains to be controversial. This article aims at providing a comprehensive review of the evidence on the use of aspirin plus clopidogrel for secondary stroke prevention, with special focus on important studies that may impact clinical practice of treating patients with stroke or transient ischemic attack.
第一作者机构：[1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China;[2]China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China;[4]Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China;
通讯作者：
通讯机构：[1]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China;[2]China Natl Clin Res Ctr Neurol Dis NCRC ND, Beijing, Peoples R China;[3]Beijing Inst Brain Disorders, Ctr Stroke, Beijing, Peoples R China;[4]Beijing Key Lab Translat Med Cerebrovasc Dis, Beijing, Peoples R China;[5]Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, 6 Tiantanxili, Beijing 100050, Peoples R China
推荐引用方式(GB/T 7714)：
Wang Yilong,Chen Weiqi,Wang Yongjun.Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Secondary Stroke Prevention[J].CURRENT CARDIOLOGY REPORTS.2015,17(10):-.doi:10.1007/s11886-015-0642-4.
APA：
Wang, Yilong,Chen, Weiqi&Wang, Yongjun.(2015).Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Secondary Stroke Prevention.CURRENT CARDIOLOGY REPORTS,17,(10)
MLA：
Wang, Yilong,et al."Dual Antiplatelet Therapy with Clopidogrel and Aspirin for Secondary Stroke Prevention".CURRENT CARDIOLOGY REPORTS 17..10(2015):-
：